{"nct_id":"NCT04158700","title":"A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer","status":"WITHDRAWN","status_verified_date":"2020-02","start_date":"2019-12-05","start_date_type":"ESTIMATED","primary_completion_date":"2023-05-11","primary_completion_date_type":"ESTIMATED","completion_date":"2023-05-11","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["LLY"]}